[Etifoxine: a new look at the GABA receptor and anxiety].
Spadone
C
C
Hôpital Saint-Louis, Paris.
Glikman
M
M
D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000679:Amygdala / Q000033:anatomy & histology / Q000187:drug effects; D014151:Anti-Anxiety Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology*; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003072:Cognition Disorders / Q000139:chemically induced / Q000453:epidemiology; D003704:Dementia / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D010078:Oxazines / Q000494:pharmacology* / Q000627:therapeutic use*; D011963:Receptors, GABA-A / Q000187:drug effects*; D012307:Risk Factors
D000305:Adrenal Cortex Hormones; D014151:Anti-Anxiety Agents; D010078:Oxazines; D011963:Receptors, GABA-A; C002125:etifoxine